DOI: 10.1039/C3OB41058G
Page 7 of 10
Organic & Biomolecular Chemistry
reduced pressure. The product was purified on Combiflash
chromatograph using alumina column (12 g) eluting with
CHCl3/CH2Cl2 gradient (CHCl3/CH2Cl2 1:1 to CHCl3 (6 min)).
Product 5 was crystallized on a watch glass and obtained as a
CHCl3/hexane gradient (flow rate: 30 mL/min; CHCl3/hexane 1:1 60 dark green solid (64 mg, 80%). UV-vis λmax(CHCl3)/nm 283
(6 min)). Product 3 was crystallized on a watch glass and
obtained as a dark green solid (108 mg, 78%). UV-vis
λmax(CHCl3)/nm 284 (ε/dm3 mol-1 cm-1 54740), 442 (9800) and
662 (23120). δH(300 MHz; CDCl3; Me4Si): 0.81-0.93 (6H, m, 22-
(ε/dm3 mol-1 cm-1 53130), 412 (9870) and 647 (24310). δH(300
MHz; CDCl3; Me4Si): 0.80-0.94 (6H, m, 22-H), 1.19-1.52 (20H,
m, 17-21-H), 1.62-1.85 (4H, m, 16-H), 1.86-2.11 (2H, m, b-H),
2.12-2.46 (2H, m, c-H), 3.22 (2H, d, J 6.7, COCH2), 3.40-3.75
5
H), 1.18-1.54 (20H, m, 17-21-H), 1.65-1.86 (4H, m, 16-H), 1.95- 65 (2H, m, a-H), 4.06-4.33 (4H, m, 15-H), 4.48-4.66 (2H, m, e-H),
2.15 (2H, m, b-H), 2.16-2.41 (2H, m, c-H), 3.43-3.77 (2H, m, a-
5.14-5.28 (2H, m, CH=CH2), 5.86-6.05 (1H, m, CH=CH2), 4.75
(1H, br s, d-H), 7.32-7.41 (2H, m, 5″-H), 7.77-7.84 (1H, m,
phenylene-H), 7.85-7.93 (5H, m, 4″-H, 13-H, phenylene-H), 7.98
(2H, d, J 8.2, 6-H, phenylene-H), 8.50-8.71 (5H, m, 3″-H, 7-H,
10 H), 3.77-4.11 (2H, m, e-H), 4.12-4.30 (4H, m, 15-H), 4.59-4.69
(2H, m, f-H), 4.69-4.80 (1H, m, d-H), 7.32-7.41 (7H, m, 5″-H, g-
H), 7.80 (1H, d, J 8.5, 13-H), 7.82-7.95 (5H, m, 4″-H, phenylene-
H), 8.00 (2H, d, J 8.2, 6-H, phenylene-H), 8.39-8.48 (1H, m, 14- 70 11-H, 14-H), 8.71-8.76 (2H, m, 6″-H), 8.78 (2H, s, 3′-H), 8.81
H), 8.62-8.67 (2H, m, 7-H, 11-H), 8.70 (2H, d, J 7.9, 3″-H), 8.73-
15 8.77 (2H, m, 6″-H), 8.80 (2H, s, 3′-H), 8.83 (1H, s, 4-H). MS
(ESI-TOF, CH3CN): m/z = 1111.5450 [M+H]+ (calcd. for
C73H70N6O5 1111.5486).
(1H, s, 4-H). MS (ESI-TOF, CH3CN): m/z = 1088.5270 [M]+
(calcd. for C70H68N6O6 1088.5200).
(1-(12-(4-([2,2':6',2''-terpyridin]-4'-yl)phenyl)-2,9-dioctyl-
1,3,8,10-tetraoxo-1,2,3,8,9,10-hexahydroanthra[2,1,9-
75 def:6,5,10-d'e'f']diisoquinolin-5-yl)pyrrolidin-2-yl)methyl 4-
(triethoxysilyl)butanoate (6)
5-(4-([2,2':6',2''-terpyridin]-4'-yl)phenyl)-12-(2-
(hydroxymethyl)pyrrolidin-1-yl)-2,9-dioctylanthra[2,1,9-
20 def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone (4)
All the glassware was dried in oven (150 °C, 2 h) before use. The
reaction flask was sealed with a septum, placed on an ice bath,
and kept under constant argon flow. Compound 5 (15 mg, 0.014
80 mmol) was dissolved in distilled toluene (1 mL) and added to the
flask. Triethoxysilane (0.46 mL, 2.5 mmol) and Karstedt catalyst
(platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex
solution (Pt ~2%) in xylene; 17.2 μL, 2.07 μmol) were added, and
the mixture was stirred in cold under argon. After 10 min, argon
85 was removed and after 1 h the stirring was continued at room
temperature for 3 h more. The crude product was evaporated
under reduced pressure using a mechanical vacuum pump.
Purification was done on Combiflash chromatograph using an
alumina column (12 g, purged with argon) eluting with
90 CHCl3/EtOH gradient (flow rate: 30 mL/min; CHCl3 (0.5 min),
CHCl3/EtOH 10:1 (2 min)). Product 6 was obtained as a dark
green solid (13 mg, 76%). δH(300 MHz; CDCl3; Me4Si): 0.51-
0.71 (2H, m, COC2H4CH2Si), 0.82-0.92 (6H, m, 22-H), 1.13-1.49
(29H, m, 17-21-H, Si(OCH2CH3)3), 1.65-1.86 (6H, m, 16-H,
95 COCH2CH2CH2Si), 1.88-2.31 (4H, m, c-H, b-H), 2.33-2.53 (2H,
m, COCH2C2H4Si), 3.64-3.91 (8H, m, Si(OCH2CH3)3, a-H), 4.11-
4.31 (4H, m, 15-H), 4.41-4.64 (2H, m, e-H), 4.77 (1H, br s, d-H),
7.34-7.41 (2H, m, 5″-H), 7.78-7.83 (1H, m, phenylene-H), 7.85-
7.98 (5H, m, 4″-H, 13-H, phenylene-H), 8.03 (2H, d, J 8.2, 6-H,
100 phenylene-H), 8.52-8.72 (5H, m, 3″-H, 7-H, 11-H, 14-H), 8.72-
8.77 (2H, m, 6″-H), 8.80 (2H, s, 3′-H), 8.83 (1H, s, 4-H). MS
(ESI-TOF, CH3CN): m/z = 1253.6212 [M+H]+ (calcd. for
C76H84N6O9Si 1253.6147).
Compound 3 (98 mg, 0.09 mmol) was dissolved in dry CH2Cl2 (5
mL) and stirred in an ice bath under a drying tube for 1 h. BBr3
(1M solution in CH2Cl2; 105 μL, 0.105 mmol) was added in five
different portions with an interval of 30 min. The progress of the
25 reaction was closely monitored by TLC analysis. After complete
consumption of the starting material (4 h), the reaction was
quenched by addition of MeOH (10 mL). The reaction mixture
was washed with water (3 × 40 mL) and the organic phase was
evaporated under reduced pressure. The crude product was
30 purified on Combiflash chromatograph using alumina column (12
g) eluting with CHCl3 (flow rate: 30 mL/min). Product 4 was
isolated as a dark green solid (87 mg, 97%). δH(300 MHz; CDCl3;
Me4Si): 0.78-0.94 (6H, m, 22-H), 1.17-1.52 (20H, m, 17-21-H),
1.69-1.82 (4H, m, 16-H), 1.83-2.06 (2H, m, b-H), 2.06-2.42 (2H,
35 m, c-H), 2.89 (1H, br s, OH), 3.42-3.68 (2H, m, a-H), 3.78-4.08
(2H, m, e-H), 4.09-4.32 (4H, m, 15-H), 4.47-4.66 (1H, m, d-H),
7.32-7.41 (2H, m, 5″-H), 7.54 (1H, d, J 7.9, 13-H), 7.62-7.71
(2H, m, phenylene-H), 7.85-7.94 (3H, m, 4″-H, phenylene-H),
7.99 (2H, d, J 8.2, 6-H, phenylene-H), 8.33-8.39 (1H, m, 7-H),
40 8.48 (1H, s, 11-H), 8.54 (1H, d, J 7.9, 14-H), 8.65-8.70 (2H, m,
3″-H), 8.70-8.75 (2H, m, 6″-H), 8.77 (2H, s, 3′-H), 8.81 (1H, s, 4-
H). MS (ESI-TOF, CH3CN): m/z = 1021.5068 [M+H]+ (calcd. for
C66H64N6O5 1021.5016).
(1-(12-(4-([2,2':6',2''-terpyridin]-4'-yl)phenyl)-2,9-dioctyl-
45 1,3,8,10-tetraoxo-1,2,3,8,9,10-hexahydroanthra[2,1,9-
def:6,5,10-d'e'f']diisoquinolin-5-yl)pyrrolidin-2-yl)methyl
but-3-enoate (5)
5,12-bis(4-([2,2':6',2''-terpyridin]-4'-yl)phenyl)-2,9-
105 dioctylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-
1,3,8,10(2H,9H)-tetraone (8)
Compound 4 (75 mg, 0.073 mmol) was dissolved in CH2Cl2 (5
mL). DCC (30 mg, 0.15 mmol), DMAP (4 mg, 0.03 mmol) and
50 3-butenoic acid (12.5 μL, 0.15 mmol) were added to the solution,
and the mixture was stirred at room temperature for 3.5 h. The
solvent was evaporated under reduced pressure. The crude
1,7-Dibromo-PDI
def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone]11, 19 (50
mg, 0.06 mmol), compound (62 mg, 0.14 mmol),
7
[5,12-dibromo-2,9-dioctylanthra[2,1,9-
1
product was dissolved in a few milliliters of EtOAc, the flask was 110 tetrabutylammonium chloride (4 mg, 0.013 mmol) and
frozen under cold water and filtered through a cotton plug. This
55 procedure was done twice. The product was purified on
Combiflash chromatograph using alumina column (12 g) eluting
with CHCl3 (flow rate: 30 mL/min) and second purification using
Pd(dppf)Cl2·CH2Cl2 (11 mg, 0.013 mmol) were dissolved in a
two-phase mixture of toluene (5 mL) and 1M K2CO3 (aq) (5 mL).
The reaction mixture was stirred at 90 °C for 18 h. The organic
phase was separated and washed with water (2 × 30 mL). The
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 7